Skip to main content
Diagnos Inc logo

Diagnos Inc — Investor Relations & Filings

Ticker · ADK ISIN · CA2524423068 LEI · 254900ZF529VWZDVUS82 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 288 across all filing types
Latest filing 2025-10-08 Regulatory Filings
Country CA Canada
Listing TSXV ADK

About Diagnos Inc

https://www.diagnos.com/

Diagnos Inc. is a technology company specializing in software-based services for the healthcare sector, focusing on the early detection of critical health problems. The company leverages its proprietary FLAIRE Artificial Intelligence (AI) platform, which combines contextual imaging and data analysis to develop algorithms, process images, and analyze data. A primary application of this technology is AI retina analysis for screening and monitoring diseases, such as diabetes, to prevent vision loss. Diagnos aims to enable digital transformation in healthcare by providing cost-effective early detection solutions to primary care facilities and specialists across international markets, including North America and Latin America.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing the successful completion of an annual external compliance audit (MDSAP) but does not itself constitute a formal audit report or detailed financial filing. It is not an earnings release, board change, regulatory form attachment, dividend notice, or other specific category. It is a general corporate announcement regarding regulatory compliance and certification status. Therefore, it falls into the fallback category for miscellaneous regulatory announcements: Regulatory Filings (RNS).
2025-10-08 English
News release - French.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release announcing the results of votes at the company’s Annual General Meeting, specifically listing which directors were elected and other vote outcomes. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2025-09-25 French
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release titled “DIAGNOS Announces Voting Results of Meeting of Shareholders.” It provides the official outcomes of the annual shareholder meeting, including election of directors and appointment of auditors. These are clear voting results announcements, fitting the Declaration of Voting Results & Voting Rights Announcements category. There is no indication it is the full annual report, management discussion, or other type. Therefore, it is classified as a DVA.
2025-09-25 English
Material change report (amended) - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a Canadian National Instrument 51-102F3 Material Change Report disclosing the closing of a non-brokered private placement and related financing terms. This is a direct update on the company’s capital/financing activities rather than a full annual/interim report or simple regulatory notice. Therefore it best fits the “Capital/Financing Update” category.
2025-09-16 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the closing of a non-brokered private placement, detailing the issuance of debentures and warrants, proceeds use, related-party considerations, and regulatory approvals. This clearly relates to company fundraising and capital structure activities, fitting the Capital/Financing Update category.
2025-09-05 English
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is labeled as Form 51-102F3 “Material Change Report” under Canadian National Instrument 51-102. It details the closing of a non-brokered private placement (10 units of $10k each) for gross proceeds of $100,000, including terms of convertible debentures and warrants. This is a company fundraising/capital structure update. Therefore, it falls under Capital/Financing Update.
2025-09-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.